Merck
  • Home
  • Search Results
  • The role of Snf5 in the osteogenic differentiation potential during replicative senescence of rat mesenchymal stromal cells.

The role of Snf5 in the osteogenic differentiation potential during replicative senescence of rat mesenchymal stromal cells.

Mechanisms of ageing and development (2018-02-06)
Shangrong Wu, Nana Han, Yong Zheng, Chengjun Hu, Yueshan Lei
ABSTRACT

The osteogenic capacities of bone marrow-derived stromal cells (BMSCs) diminish during replicative senescence, and these changes affect the success of therapeutic application of BMSCs. In this study, we sought to explore the molecular mechanisms underlying the osteogenic differentiation capacities that occur during replicative senescence. It is well known that Oct4 is a key transcription factor essential for maintaining differentiation capacities of the stem cells. In this study, we found that BMSCs at passage 6 (replicative senescent BMSCs) showed marked decreases in the osteogenic differentiation potential and the level of Oct4. These were accompanied by reduced levels of Snf5 and histone H3 lysine-4 trimethylation (H3K4me3) in the Oct4 promoter. In BMSCs at passage 2, knockdown of Snf5 diminished expression of Oct4 and disrupted the up-regulation of alkaline phosphatase (ALP) and runt-related transcription factor 2 (Runx2) after osteogenic differentiation induction, which was accompanied by a reduction in Snf5 and H3K4me3 binding to the Oct4 promoter. These findings indicate that the decreased level of Snf5 binding to the promoter region of the Oct4 gene down-regulated the expression of Oct4, which may be the mechanism underlying the decline in osteogenic capacities in replicative senescent BMSCs.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Lys-Lys-Lys-Lys, ≥95% (TLC)